Zynex PE Ratio 2006-2019 | ZYXI

Current and historical p/e ratio for Zynex (ZYXI) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zynex PE ratio as of September 20, 2019 is 34.45.
Zynex PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-20 9.99 inf
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.324B $0.032B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.167B 20.94
Abbott Laboratories (ABT) United States $147.719B 27.77
Stryker (SYK) United States $82.752B 28.62
Boston Scientific (BSX) United States $60.302B 29.25
Baxter (BAX) United States $44.623B 27.06
EssilorLuxottica Societe Anonyme (ESLOY) France $31.677B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.159B 18.66
Lonza Group Ag (LZAGY) Switzerland $25.836B 0.00
Coloplast (CLPBY) Denmark $25.785B 41.16
Terumo (TRUMY) Japan $23.720B 27.27
Smith & Nephew SNATS (SNN) United Kingdom $20.893B 0.00
ResMed (RMD) United States $19.328B 36.86
Sunny Optical Technology (SNPTF) China $16.573B 0.00
Bio-Rad Laboratories (BIO) United States $10.288B 55.15
Insulet (PODD) United States $9.390B 556.43
Canopy Growth (CGC) Canada $8.891B 0.00
Perrigo (PRGO) Ireland $7.516B 13.85
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.032B 20.96
Haemonetics (HAE) United States $6.572B 49.59
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.122B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.982B 0.00
Neogen (NEOG) United States $3.929B 65.23
NuVasive (NUVA) United States $3.473B 27.68
ICU Medical (ICUI) United States $3.302B 21.42
Hutchison China MediTech (HCM) China $2.696B 0.00
Quidel (QDEL) United States $2.660B 26.42
Agios Pharmaceuticals (AGIO) United States $2.133B 0.00
National Vision Holdings (EYE) United States $1.958B 42.25
Cardiovascular Systems (CSII) United States $1.782B 0.00
Aphria (APHA) $1.546B 0.00
VAREX IMAGING (VREX) United States $1.100B 25.34
Lantheus Holdings (LNTH) United States $1.024B 26.92
AtriCure (ATRC) United States $0.993B 0.00
Phibro Animal Health (PAHC) United States $0.907B 14.75
Omeros (OMER) United States $0.898B 0.00
NanoString Technologies (NSTG) United States $0.863B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 19.77
PetIQ (PETQ) United States $0.768B 18.15
Cerus (CERS) United States $0.748B 0.00
LeMaitre Vascular (LMAT) United States $0.699B 41.41
MacroGenics (MGNX) United States $0.630B 0.00
Surmodics (SRDX) United States $0.628B 119.36
Quanterix (QTRX) United States $0.610B 0.00
TG Therapeutics (TGTX) United States $0.573B 0.00
OraSure Technologies (OSUR) United States $0.472B 21.83
Meridian Bioscience (VIVO) United States $0.422B 13.16
BioLife Solutions (BLFS) United States $0.394B 129.63
Utah Medical Products (UTMD) United States $0.364B 26.64
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.360B 0.00
Owens & Minor (OMI) United States $0.353B 10.59
United Health Products (UEEC) United States $0.258B 0.00
Bovie Medical (APYX) United States $0.249B 0.00
Rockwell Medical (RMTI) United States $0.209B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Chimerix (CMRX) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 10.20
Female Health (VERU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
United-Guardian (UG) United States $0.087B 20.48
Nephros (NEPH) United States $0.065B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.028B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00